Drug Patent Expirations in December 2009

Drug Patent Expirations for December 2009

TradenameApplicantGeneric NamePatent Number Patent Expiration
MIGRANALValeantdihydroergotamine mesylate5,169,849Dec 8, 2009
PHOTOFRINAxcan Scandipharmporfimer sodium5,145,863Dec 15, 2009
XENICALHoffmann La Rocheorlistat4,598,089*PEDDec 18, 2009
CEDAXSciele Pharma Incceftibuten dihydrate4,812,561Dec 20, 2009
OXILAN-300Guerbetioxilan4,954,348Dec 21, 2009
OXILAN-350Guerbetioxilan4,954,348Dec 21, 2009
DEFINITYLantheus Medclperflutren6,146,657Dec 22, 2009
ZANTAC 150Glaxosmithklineranitidine hydrochloride5,102,665*PEDDec 23, 2009
VALTREXGlaxosmithklinevalacyclovir hydrochloride4,957,924*PEDDec 23, 2009
ZIAGENGlaxosmithklineabacavir sulfate5,089,500*PEDDec 26, 2009
TRIZIVIRGlaxosmithklineabacavir sulfate; lamivudine; zidovudine5,089,500*PEDDec 26, 2009
EPZICOMSmithkline Beechamabacavir sulfate; lamivudine5,089,500*PEDDec 26, 2009
CORVERTPharmacia And Upjohnibutilide fumarate5,155,268Dec 28, 2009

*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Courtesy of DrugPatentWatch.com

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: